<DOC>
	<DOCNO>NCT01691261</DOCNO>
	<brief_summary>Phase 1 trial retinal pigment epithelium replacement subject wet age-related macular degeneration rapidly progress vision loss</brief_summary>
	<brief_title>A Study Of Implantation Of Retinal Pigment Epithelium In Subjects With Acute Wet Age Related Macular Degeneration</brief_title>
	<detailed_description>Phase 1 , open-label , safety feasibility study implantation PF-05206388 ( human embryonic stem cell derive retinal pigment epithelium ) subject wet age relate macular degeneration rapid vision loss</detailed_description>
	<mesh_term>Macular Degeneration</mesh_term>
	<criteria>Male /or postmenopausal female subject age 60 year . Diagnosis wet Agerelated Macular Degeneration ( AMD ) plus rapid recent vision decline An informed consent document sign date subject legal representative . Pregnant female ; breastfeed female ; female childbearing potential . Treatment investigational drug within 30 day ( determined local requirement , whichever long ) 5 halflives precede first dose study medication . Current previous significant ocular disease study eye , determine investigator .</criteria>
	<gender>All</gender>
	<minimum_age>60 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>